What This Top Dividend Portfolio Is Holding Now: HSBC Holdings plc, GlaxoSmithKline plc And Centrica PLC

HSBC Holdings plc (LON:HSBA), GlaxoSmithKline plc (LON:GSK) and Centrica PLC (LON:CNA) are top dividend holdings of Murray Income Trust plc (LON:MUT).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

hsbcMurray Income Trust (LSE: MUT) announced its annual results last month, and delivered “the 40th consecutive year of annual dividend increases”. At a current share price of 704p, the trust yields 4.4%.

Picking great dividend shares has helped Murray Income outperform the FTSE All-Share Index over the past three, five and 10 years.

Let’s take a look at the three highest yielding stocks in Murray’s top 10 holdings: namely, HSBC (LSE: HSBA) (NYSE: HSBC.US), GlaxoSmithKline (LSE: GSK) and Centrica (LSE: CNA).

HSBC

HSBC, which came through the financial crisis better than many of its rivals, is ahead of the field in cleaning up its balance sheet, and is probably one of the most investible banks in Europe.

HSBC has averaged annual dividend growth in high single digits since 2009, and analysts are forecasting more of the same to come.

The company offers a significantly higher income than its peers — an income that’s recently become even more attractive. HSBC’s shares have dropped 8% over the last four weeks, pushing the 12-month forward yield up to 5.5% at a current price of 612p.

HSBC not only beats its banking rivals on yield, but also trounces the 3.5% on offer from the wider market.

GlaxoSmithKline

GlaxoSmithKline is in the midst of a bribery scandal. It isn’t the first company to face this kind of situation, and it won’t be the last. If history is any guide, there should be little long-term damage to the company.

Glaxo has averaged annual mid-single-digits dividend growth for shareholders since 2009. Analysts see this continuing, albeit at the lower end of the mid-single-digits range.

While the UK’s top pharmaceuticals group is set to deliver lesser income growth than HSBC in the immediate future, the starting yield is significantly higher than the bank’s: Glaxo offers 6.3% at a current share price of 1,304p.

Like HSBC, Glaxo is the leader for yield within its sector.

Centrica

The UK’s ‘Big Six’ energy companies — which include Centrica, the owner of British Gas — are under intense political and regulatory scrutiny at the moment. Utilities tend to go through such periods from time to time … but come out of the other side still delivering for shareholders.

Centrica was posting double-digits dividend growth five years ago. This subsequently moderated to mid single digits, and analysts see a further softening to low single digits growth for this year and next.

The political pressure on the energy firms of late and the recent broad stock market sell-off mean Centrica’s shares are trading at a 52-week low of 281p, giving a Glaxo-matching 12-month forward yield of 6.3%.

And once again, like Glaxo and HSBC, Centrica is the top stock within its sector for yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s the dividend forecast for Lloyds shares out to 2026

Predictions for dividend progress from Lloyds shares over the next few years look upbeat now. But the path might not…

Read more »

Middle-aged black male working at home desk
Investing Articles

1 of my favourite UK dividend shares this December!

Diageo's one of the best dividend growth shares in my Stocks and Shares ISA. At current prices I'm considering buying…

Read more »

Investing Articles

3 REITs I’d consider buying to target a long-term second income

I'm seeking ways to make a market-beating second income. These real estate investment trusts (REITs) could be just what I've…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

2 shares I changed my mind about in today’s stock market

This writer explains why he changed his opinion on these two shares, even though both are highly valued in today's…

Read more »

Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Google office headquarters
Investing Articles

1 reason I like buying S&P 500 shares – and 1 reason I don’t

Will this investor try to improve his potential returns by focusing more on S&P 500 shares instead of British ones?…

Read more »

Young woman holding up three fingers
Investing Articles

3 SIPP mistakes to avoid

Our writer explains a trio of potentially costly errors he tries to avoid making when investing his SIPP, on an…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how (and why) I’d start buying shares with £25 a week

Our writer uses his investment experience and current approach to explain how he would start buying shares on a limited…

Read more »